Bio-Techne TECH Financing Cash Flow
Financing Cash Flow at other companies
Other financials
Where this comes from
Reported directly by Bio-Techne in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInFinancingActivities.
The official record: Bio-Techne’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Bio-Techne's financing cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Bio-Techne's financing cash flow?
- Bio-Techne (TECH) reported financing cash flow of -$42.72M in Q1 2026.
- How has Bio-Techne's financing cash flow changed year-over-year?
- Bio-Techne's financing cash flow increased by 37.2% year-over-year, from -$68.05M to -$42.72M.
- What is the long-term trend for Bio-Techne's financing cash flow?
- Over 2 years (2022 to 2025), Bio-Techne's financing cash flow has grown at a 2.3% compound annual growth rate (CAGR), from -$242.85M to -$253.91M.
- What does financing cash flow mean?
- The total net cash movement from debt and equity transactions.
- How do you interpret financing cash flow?
- Negative values often indicate debt repayment or share buybacks, while positive values suggest capital raising or borrowing.
- How does financing cash flow compare across companies?
- Used to compare how companies fund their growth versus returning capital to shareholders.